Article

Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung cancer cell line, PC10

Division of Cancer Gene Regulation, Research Section of Disease Control, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan.
British Journal of Cancer (Impact Factor: 4.82). 03/2003; 88(4):606-12. DOI: 10.1038/sj.bjc.6600739
Source: PubMed

ABSTRACT Gelsolin expression is frequently downregulated in lung cancer and several types of different human cancers. To examine the effects of gelsolin restoration on tumorigenicity, we here stably expressed various levels of gelsolin via gene transfer in lung cancer cells (squamous cell carcinoma line, PC10). We observed the alterations in tumorigenicity in vivo when implanted in nude mice, and the changes in growth properties in vitro. As compared to parental cells and control clones, gelsolin transfectants highly reduced tumorigenicity and repressed cell proliferation. Moreover, we investigated bradykinin-induced responses in gelsolin-overexpressing clones, because agonist-stimulated activation of the phospholipases C (PLC)/protein kinase C (PKC) signal transduction pathway is critical for cell growth and tumorigenicity. Bradykinin promotes phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis by PLC and translocation of various PKC isoforms from the cytosolic fraction to the particulate fraction. Bradykinin treatment did not increase inositoltriphosphate (IP3) production and induce the membrane fractions of PKC alpha and PKC gamma in gelsolin tranfectants, while it induced PIP2 hydrolysis and increased the fractions in parental and control clones. These results suggest that gelsolin suppressed the activation of PKCs involved in phospholipid signalling pathways, inhibiting cell proliferation and tumorigenicity.

0 Followers
 · 
130 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nm23-H1 has been identified as a metastasis suppressor gene but its protein interactions have yet to be understood with any mechanistic clarity. In this study, we evaluated the proteomic spectrum of interactions made by Nm23-H1 in 4T1 murine breast cancer cells derived from tissue culture, primary mammary tumors and pulmonary metastases. By this approach, we identified the actin-severing protein gelsolin as binding partner for Nm23-H1, verifying their interaction by co-immunoprecipitation in 4T1 cells as well as in human MCF7, MDA-MB-231T and MDA-MB-435 breast cancer cells. In gelsolin transfected cells, co-expression of Nm23-H1 abrogated the actin-severing activity of gelsolin. Conversely, actin severing by gelsolin was abrogated by RNAi-mediated silencing of endogenous Nm23-H1. Tumor cell motility was negatively affected in parallel with gelsolin activity, suggesting that Nm23-H1 binding inactivated the actin depolymerizing function of gelsolin to inhibit cell motility. Using indirect immunoflourescence to monitor complexes formed by gelsolin and Nm23-H1 in living cells, we observed their co-localization in a perinuclear cytoplasmic compartment that was associated with the presence of disrupted actin stress fibers. In vivo analyses revealed that gelsolin overexpression increased the metastasis of orthotopically implanted 4T1 or tail vein injected MDA-MB-231T cells (p=0.001, p=0.04, respectively), along with the proportion of mice with diffuse liver metastases, an effect ablated by co-expression of Nm23-H1. We observed no variation in proliferation among lung metastases. Our findings suggest a new actin-based mechanism that can suppress tumor metastasis.
    Cancer Research 08/2013; 73(19). DOI:10.1158/0008-5472.CAN-13-0368 · 9.28 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Hidden variability is a fundamentally important issue in the context of gene expression studies. Collected tissue samples may have a wide variety of hidden effects that may alter their transcriptional landscape significantly. As a result their actual differential expression pattern can be potentially distorted, leading to inaccurate results from a genome-wide testing for the important transcripts. We present an R package svapls that can be used to identify several types of unknown sample-specific sources of heterogeneity in a gene expression study and adjust for them in order to provide a more accurate inference on the original expression pattern of the genes over different varieties of samples. The proposed method implements Partial Least Squares regression to extract the hidden signals of sample-specific heterogeneity in the data and uses them to find the genes that are actually correlated with the phenotype of interest. We also compare our package with three other popular softwares for testing differential gene expression along with a detailed illustration on the widely popular Golub dataset. Results from the sensitivity analyes on simulated data with widely different hidden variation patterns reveal the improved detection power of our R package compared to the other softwares along with reasonably smaller error rates. Application on the real-life dataset exhibits the efficacy of the R package in detecting potential batch effects from the dataset. Overall, Our R package provides the user with a simplified framework for analyzing gene expression data with a wide range of hidden variation patterns and delivering a differential gene expression analysis with substantially improved power and accuracy. The R package svapls is freely available at http://cran.r-project.org/web/packages/svapls/index.html.
    BMC Bioinformatics 07/2013; 14(1):236. DOI:10.1186/1471-2105-14-236 · 2.67 Impact Factor
  • Source

Full-text (2 Sources)

Download
17 Downloads
Available from
Jun 20, 2014